Observational Study
Copyright ©The Author(s) 2024.
World J Gastroenterol. Jul 21, 2024; 30(27): 3314-3325
Published online Jul 21, 2024. doi: 10.3748/wjg.v30.i27.3314
Figure 4
Figure 4 Receiver operating characteristic of models in training cohort and validation cohort. A: Training cohort; B: Validation cohort. ALBI: Albumin-bilirubin; MELD: Model of end-stage liver disease; PM: Posthepatectomy liver failure model.